Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Alexandra Andrews | Chief Operating Officer | 36k | -- | -- |
| Mr. Gerald Quigley | Director of Public Relations & Director | 40.31k | -- | -- |
| Dr. Thomas Duthy M.B.A., Ph.D. | Executive Director | 240k | -- | -- |
| Dr. Emanuela Russo | Chief Scientific Officer & Member of Scientific Advisory Board | -- | -- | -- |
| Associate Prof. Carolyn Ellaway | Chief Medical Officer | -- | -- | -- |
| Mr. Peter James Lawrence Griffiths B.Sc. | Chief Executive Officer of AAT Research Ltd | -- | -- | 1964 |
| Ms. Alessandra Marie Gauvin | Company Secretary | -- | -- | -- |
Neurotech International Limited
- Sector:
- Healthcare
- Industry: Medical Devices
Description
Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxation in autistic children exhibiting elevated delta band brain activity. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary NTI/Dolce cannabis strains. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia.
Corporate Governance
Upcoming Events
February 27, 2025 at 10:59 AM UTC - February 28, 2025 at 12:00 PM UTC
Neurotech International Limited Earnings Date
Recent Events
Recent Events Information Not Available